Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the Record History; removed a government funding lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:17:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a government funding notice about the NIH Clinical Center's operating status. Updated the site revision to v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.9%
    Check dated 2026-02-03T23:01:18.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    UI changes include a glossary toggle and color-coded indicators for additions and deletions in the study history, with the revision label updated to v3.4.0. The previously listed No FEAR Act data note and the older revision label (v3.3.4) are superseded by the new formatting.
    Difference
    1%
    Check dated 2026-01-27T21:32:15.000Z thumbnail image
  4. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:23:45.000Z thumbnail image
  5. Check
    78 days ago
    Change Detected
    Summary
    A new revision (v3.3.2) has been added to the record history, and the previous revision (v3.3.1) has been removed.
    Difference
    0.1%
    Check dated 2025-12-01T16:09:33.000Z thumbnail image
  6. Check
    85 days ago
    Change Detected
    Summary
    Revision history now lists a new version entry v3.3.1 and removes v3.2.0, representing a minor administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:12:02.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.